Differential polarization of serotonin transporters in axons versus soma-dendrites: An immunogold electron microscopy study

Neuroscience

Volumn 94, Issue 3, 1999, Pages 821-830

  Tao Cheng, J H ^a   Zhou, F C ^b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Extrasynaptic transmission; Immunocytochemistry; Raphe nucleus; Specific serotonin reuptake inhibitor; Synaptic cleft; Volume transmission

Indexed keywords

SEROTONIN TRANSPORTER;

ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; ELECTRON MICROSCOPY; IMMUNOGOLD STAINING; NERVE FIBER; NEUROTRANSMITTER UPTAKE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; SEROTONIN UPTAKE; SYNAPTIC TRANSMISSION;

ANIMALS; AXONS; BRAIN; CARRIER PROTEINS; CYTOPLASM; DENDRITES; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICROSCOPY, IMMUNOELECTRON; NERVE TISSUE PROTEINS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYNAPSES;

EID: 0032829125     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00373-5     Document Type: Article

References (42)

1. Aghajanian G. K. and Wang R. Y. (1978) Physiology and pharmacology of central serotonergic neurons. In Psychopharmacology: A Generation of Progress (eds Lipton M. A., DiMasco A. and Killam K. F.), pp. 171-183. Raven, New York.
2. 3H-5HT and HRP after retrograde transport. J. comp. Neurol. 203:1981;737-743.
3. Azmitia E., Gannon P. The ultrastructural localization of serotonin immunoreactivity in myelinated and unmyelinated axons within the medial forebrain bundle of rat and monkey. J. Neurosci. 3:1983;2083-2090.
4. Berger U.V., Molliver M.E., Grzanna R. Unlike systemic administration of p-chloroamphetamine, direct intracerebral injection does not produce degeneration of 5-HT axons. Expl Neurol. 109:1990;257-268.
5. Bunin M.A., Wightman R.M. Quantitative evaluation of 5-hydroxytryptamine (5-HT) neuronal release and uptake: an investigation of extrasynaptic transmission. J. Neurosci. 18:1998;4854-4860.
6. Coccaro E. F. and Murphy D. L. (1990) Serotonin in Major Psychiatric Disorders. American Psychiatric, Washington, DC.
7. Descarries L., Beaudet A., Watkins K.C. Serotonin nerve terminals in adult rat neocortex. Brain Res. 100:1975;563-588.
8. Descarries L., Audet M.A., Doucet G., Garcia S., Oleskevich S., Seguela P., Soghomonia J.J., Watkins K.C. Morphology of central serotonin neurons. Brief review of quantified aspects of their distribution and ultrastructural relationships. Ann. N. Y. Acad. Sci. 600:1990;81-92.
9. Futter C.E., Gibson A., Allchin E.H., Maxwell S., Ruddock L.J., Odorizzi G., Domingo D., Trowbridge I.S., Hopkins C.R. In polarized MDCK cells basolateral vesicles arise from clathrin-gama-adaptin-coated domains on endosomal tubules. J. Cell Biol. 141:1998;611-623.
10. Garris P.A., Ciolkowski E.L., pastore P., Wightman R.M. Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J. Neurosci. 14:1994;6084-6093.
11. Herkenham M. Mismatches between neurotansmitter and receptor localizations in brain: observations and implications. Neuroscience. 23:1987;1-38.
12. Mamounas L.A., Molliver M.E. Evidence for dual serotonergic projections to neocortex: axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PA). Expl Neurol. 102:1988;223-236.
13. Molliver M.E., Berger U.V., Mamounas L.A., Molliver D.C., O'Hearn E., Wilson M.A. Neurotoxicity of MDMA and related compounds: anatomic studies. Ann. N. Y. Acad. Sci. 600:1990;649-661.
14. Molliver M.E., Mamounas L.A., Wilson M.A. Effects of neurotoxic amphetamines on serotonergic neurons: immunocytochemical studies. NIDA Res. Monogr. 94:1989;270-305.
15. Nirenberg M.J., Vaughan R.A., Uhl G.R., Kuhar M.J., Pickle V.M. The dopamine transporter is localized to dendrite and axonal plasma membranes of nigrostriatal dopaminergic neurons. J. Neurosci. 16:1996;436-447.
16. Nirenberg M.J., Chan J., Vaughan R.A., Uhl G.R., Kuhar M.J., Pickle V.M. Immunogold localization of the dopamine transporter: an ultrastructural study of the rat ventral tegmental area. J. Neurosci. 17:1997;5255-5262.
17. Nirenberg M.J., Chan J., Pohorille A., Vaughan R.A., Uhl G.R., Kuhar M.J., Pickle V.M. The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens. J. Neurosci. 17:1997;6899-6907.
18. Nusser Z., Sieghart W., Stephenson F.A., Somogyi P. The alpha-6 subunit of the GABA A receptor is concentrated in both inhibitory and excitatory synapses on cerebellar granule cells. J. Neurosci. 16:1996;103-114.
19. O'Hearn E., Battaglia G., De Souza E.B., Kuhar M.J., Molliver M.E. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J. Neurosci. 8:1988;2788-2803.
20. Oleskevich S., Descarries L., Watkins K.C., Seguela P., Daszuta A. An ultrastructural feature of the serotonin innervation in adult rat hippocampus: an immunocytochemical description in single and serial thin sections. Neuroscience. 42:1991;777-791.
21. Owens M.J., Nemeroff C.B. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin. Chem. 40:1994;288-295.
22. 3H]5-hydroxytryptamine. Neuroscience. 6:1981;115-138.
23. Paris J.M., Cunningham K.A. Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA). Brain Res. Bull. 28:1992;115-119.
24. Peters A., Palay S. L. and Webster H. deF. (1991) The Fine Structure of the Nervous System. Neurons and their Supporting Cells. Oxford University Press, New York.
25. Pickle V.M., Nirenberg M.J., Milner T.A. Ultrastructural view of central catecholaminergic transmission: immunocytochemical localization of synthesizing enzymes, transporter and receptors. J. Neurocytol. 25:1996;843-856.
26. Qian Y., Melikian H.E., Rye D.B., Level A.I., Blakelly R.D. Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies. J. Neurosci. 15:1995;261-274.
27. Rudnick G., Wall S.C. The molecular mechanism of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc. natn. Acad. Sci. USA. 89:1992;1817-1821.
28. Scaller A.C., Lipe G.W., Ali S.F., Holson R.R., Frith C.H., Slikker W. Jr. Neuropathological evaluation by combined immunohistochemistry and degeneration-specific methods: application to methylenedioxymethamphetamine. Neurotoxicology. 9:1988;529-538.
29. Seguela P., Watkins K.C., Descarries L. Ultrastructural relationships of serotonin axon terminals in the cerebral cortex of the adult rat. J. comp. Neurol. 289:1989;129-142.
30. Seiden L.S., Sobol K.E. Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. NIDA Res. Monogr. 163:1996;251-276.
31. Simons K., Ikonen E. Sphingolipid-cholesterol rafts in membrane trafficking and signalling. Nature. 387:1997;569-572.
32. Steinbusch H. Distribution of serotonin-immunoreactivity in the central nervous system of the rat - cell bodies and terminals. Neuroscience. 6:1981;557-618.
33. Tanner V., Ploug T., Tao-Cheng J.-H. Subcellular localization of SV2 and other secretory vesicle components in PC12 cells by an efficient method of pre-embedding EM immunocytochemistry for cell cultures. J. Histochem. Cytochem. 144:1996;1481-1488.
34. Van Bockstaele E.J., Pickle V.M. Ultrastructure of serotonin-immunoreactive terminals in the core and shell of the rat nucleus accumbens: cellular substrates for interactions with catecholamine afferents. J. comp. Neurol. 334:1993;603-617.
35. Van Bockstaele E.J., Cestari D.M., Pickle V.M. Synaptic structure and connectivity of serotonin terminals in the ventral tegmental area: potential sites for modulation of mesolimbic dopamine neurons. Brain Res. 647:1994;307-322.
36. Van Bockstaele E.J., Chan J., Pickle V.M. Pre- and postsynaptic sites for serotonin modulation of GABA-containing neurons in the shell regions of the rat neurons in the shell region of the rat nucleus accumbens. J. comp. Neurol. 370:1996;116-128.
37. Wong D.T., Bymaster F.P., Engleman E.A. Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci. 57:1995;411-441.
38. Woolverton W.L., Ricaurte G.A., Forno L.S., Seiden L.S. Long term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res. 486:1989;73-78.
39. Zhou F. C. and Bledsoe S. B. (1996) Methamphetamine causes rapid varicosis, perforation and definitive degeneration of serotonin fibers: an immunocytochemical study of serotonin transporter. Neuroscience Net 1:http://www.neuroscience.com.
40. Zhou F.C., Pu C.F., Murphy J., Lumeng L., Li T.-K. Serotonergic neurons in the alcohol-preferring rats. Alcohol. 11:1994;397-403.
41. Zhou F.C., Xu Y., Bledsoe S., Lin R., Kelley M.R. Serotonin transporter antibodies: production, characterization, and localization in the brain. Molec. Brain Res. 43:1996;267-278.
42. Zhou F.C., Tao-Cheng J.-H., Segu L., Patel T., Wang Y. Serotonin transporters are located on axons beyond synaptic junctions: anatomical and functional evidence. Brain Res. 805:1998;241-254.